As las cosas, SURMOUNT-1 es un ensayo clnico fase 3 multicntrico, aleatorizado, doble ciego, paralelo y controlado con placebo que compar la eficacia y seguridad de tirzepatida 5 mg, 10 mg y 15 mg frente a placebo, ambos como complemento de una dieta baja en caloras y aumento de la actividad fsica en adultos con obesidad o sobrepeso con al menos una de las siguientes complicaciones: hipertensin, dislipidemia, apnea obstructiva del sueo o enfermedad cardiovascular 1,4
01Body composition over scale The goal is lean preservation, fat reduction, and metabolic refinement not the largest possible number on the scale
AT YOUR OWN PACE Live Q&A sessions or more expert advice from our speakers (you can pre-submit questions) YOUR OWN PACEBONUS UPDATES As this is a new area of research, and new updates are constantly being published, you will get updates to key changes in the research for GLP-1 for the next year
Learn more about these cutting-edge solutions by scheduling a consultation with Dr